Up-Regulation of α4β7 Integrin on Peripheral T Cell Subsets Correlates with the Development of Acute Intestinal Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Up-Regulation of α4β7 Integrin on Peripheral T Cell Subsets Correlates with the Development of Acute Intestinal Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation

Published:2009-09 Issue:9 Volume:15 Page:1066-1076
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Chen Yi-Bin,Kim Haesook T.,McDonough Sean,Odze Robert D.,Yao Xiaopan,Lazo-Kallanian Suzan,Spitzer Thomas R.,Soiffer Robert,Antin Joseph H.,Ritz Jerome

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Graft-versus-host disease;Ferrara;N Engl J Med,1991

2. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation;Hill;Blood,2000

3. Leukocyte migration and graft-versus-host disease;Wysocki;Blood,2005

4. Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant;Johansson-Lindbom;J Exp Med,2003

5. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells;Mora;Nature,2003

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic modeling of vedolizumab for graft‐versus‐host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant;Pharmacology Research & Perspectives;2024-09-04

2. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease;Frontiers in Immunology;2024-07-03

3. Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial;Nature Medicine;2024-06-06

4. Vedolizumab provides a new hope of acute graft-versus-host disease prophylaxis through immune regulation;The Innovation Medicine;2024

5. Novel developments in the prophylaxis and treatment of acute GVHD;Blood;2023-09-21